Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Lilly reports encouraging trial results for its next-gen GLP-1 shot

Patients taking the highest dose of retatrutide lost 16.8% of their body weight after 40 weeks, more than its current bestseller, tirzepatide.

J. Edward Moreno
Author: J. Edward Moreno

Written by

J. Edward Moreno

in

Business
←WATCH: Best friends of 50 years go viral after one shares cancer journey
21 Essential Books That Fiercely Celebrate Black Womanhood→

More posts

  • Pure Joy: Photographer Laylah Amatullah Barrayn Captures Her First ESSENCE Festival Of Culture

  • Angry crowd confronts Republican Rep. Mike Flood at Nebraska town hall

  • Rhea Seehorn celebrates her ‘Pluribus’ Emmy nomination as she waits to hear about Carol and the atom bomb

  • Emmy Nominations Analysis: ‘The Pitt’ And ‘Hacks’ Dominance Proves It Helps To Be On A Show Voters Actually Watch

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube